This project aims to understand the needs of rheumatologists and other specialties in the care of patients with SLE - LESBRA

Study identifier:D3461R00089

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

Generating Evidence Study for Systemic Lupus Erythematosus using different types of methodologies

Medical condition

Systemic Lupus Erythematosus

Phase

Phase 4

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

1000

Study type

Observational

Age

18 Years - 100 Years

Date

Study Start Date: 30 Nov 2024
Estimated Primary Completion Date: 20 Dec 2024
Estimated Study Completion Date: 20 Dec 2024

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria